SavedAdd your journal

Journals / JAREM / 2021 / Cilt: 11 - Sayı: 3

The PR Interval Predicted Major Adverse Cardiovascular Events in Patients with Acute Coronary Syndrome Who Underwent Percutaneous Coronary Intervention: 3 Years Follow-up Results

Primer Perkütan Koroner Girişim Uygulanan Akut Koroner Sendrom Hastalarında PR Mesafesi Majör İstenmeyen Olayları Öngörmüştür: 3 Yıllık Takip SonuçlarıPrimer Perkütan Koroner Girişim Uygulanan Akut Koroner Sendrom Hastalarında PR Mesafesi Majör İsten

Göksel Çinier
Mustafa Çetin
Fatih Kahraman
Ahmet Seyda Yılmaz
Ömer Faruk Çırakoğlu
Journal
JAREM
Pages
241–248
Publication Date
2022-10-18
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

MACE developed in 38 patients (21.4%) who were older (p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: It is crucial to identify the high-risk group in acute coronary syndrome (ACS) patients who underwent percutaneous coronary intervention (PCI).
📊
Key Findings & Data:Methods: Patients diagnosed with ACS and who underwent PCI between January 2015 and July 2018 were included in the study.
💡
Conclusion & Impact:MACE developed in 38 patients (21.4%) who were older (p
🔬Design:Research Article
📍Scope:2015 Verileri
⚙️Variables:Domain Parameters

Abstract

Objective: It is crucial to identify the high-risk group in acute coronary syndrome (ACS) patients who underwent percutaneous coronary intervention (PCI). To date, various stratification tools have been developed to predict adverse events. However, the PR interval is a readily available parameter in routine clinical practice. This study aimed to investigate the role of the PR interval in predicting major adverse cardiovascular events (MACE) in patients with ACS who were performed PCI. Methods: Patients diagnosed with ACS and who underwent PCI between January 2015 and July 2018 were included in the study. Patients were followed up for an average of 3.2 years. Electrocardiogram was obtained from all patients on admission to the hospital. The PR interval was measured by the semi-automatic application tool. The primary outcome was all-cause mortality, new-onset decompensated heart failure, cerebrovascular event, and recurrent revascularization. Results: The mean age of total 177 ACS patients was 58.7±10.3 years and 150 (84.7%) of them were male. MACE developed in 38 patients (21.4%) who were older (p

Özet

Amaç: Akut koroner sendrom (AKS) hastalarında yüksek riskli grupları belirlemek önemlidir. Şimdiye kadar çeşitli sınıflandırma araçları geliştirilmiştir. PR intervali rutin günlük pratikte kolay elde edilebilir bir parametredir. Bu çalışmada perkütanöz koroner girişim (PCI) yapılmış AKS hastalarında PR mesafesinin uzun dönem majör istenmeyen advers olayları (MACE) öngörmedeki etkisini araştırmayı amaçladık. Yöntemler: Ocak 2017 ile Temmuz 2017 tarihleri arasında PCI uygulanan toplamda 177 AKS hastası çalışmaya dahil edildi. Ortalama 3,2 yıl boyunca hastalar takip edildi. Elektrokardiyografi verileri tüm hastalardan başvuru anında elde edildi ve yarı otomatik uygulama aracılığıyla PR aralıkları ölçüldü. Primer sonlanım noktası tüm sebeplere bağlı ölüm, yeni başlayan dekompanse kalp yetmezliği, serebrovasküler olay ve tekrarlayan revaskülarizasyon olarak belirlendi. Bulgular: Çalışmaya dahil edilen toplam 177 hastanın yaş ortalaması 58,7±10,3 yıl ve 150 (%84,7) kişi erkekti. Hastaların 38 tanesinde (%21,4) MACE gelişti ve bu grupta erkek cinsiyeti hakimiyeti olmakla beraber (p=0,032) daha yaşlı olduğu görüldü (p

🔖

Cite This Article

Çinier, G., Çetin, M., Kahraman, F., Yılmaz, A. S., Çırakoğlu, Ö. F. (2022). The PR Interval Predicted Major Adverse Cardiovascular Events in Patients with Acute Coronary Syndrome Who Underwent Percutaneous Coronary Intervention: 3 Years Follow-up Results. JAREM, Cilt: 11 - Sayı: 3, 241–248. https://ajindex.com/articles/558164

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. Aguado-Romeo MJ, Márquez-Calderón S, Buzón-Barrera ML. Hospital mortality in acute coronary syndrome: differences related to gender and use of percutaneous coronary procedures. BMC Health Serv Res 2007; 7: 110
  2. Granger CB, Goldberg RJ, Dabbous O, Pieper KS, Eagle KA, Cannon CP, et al. Predictors of hospital mortality in the global registry of acute coronary events. Arch Intern Med 2003; 163: 2345-53
  3. Lehmacher J, Neumann JT, Sörensen NA, Goßling A, Haller PM, Hartikainen TS, et al. Predictive value of serial ecgs in patients with suspected myocardial infarction. J Clin Med 2020; 9: 2303
  4. Wang X, Zhang L, Gao C, Zhu J, Yang X. Tpeak-Tend/QT interval predicts ST-segment resolution and major adverse cardiac events in acute ST-segment elevation myocardial infarction patients undergoing percutaneous coronary intervention. Medicine (Baltimore) 2018; 97: e12943. doi: 10.1097/MD.0000000000012943
  5. Timóteo AT, Mendonça T, Aguiar Rosa S, Gonçalves A, Carvalho R, Ferreira ML, et al. Prognostic impact of bundle branch block after acute coronary syndrome. Does it matter if it is left of right? Int J Cardiol Heart Vasc 2019; 22: 31-4
  6. Lévy S. Bundle branch blocks and/or hemiblocks complicating acute myocardial ischemia or infarction. J Interv Card Electrophysiol 2018; 52: 287-92
  7. Wang SL, Wang CL, Wang PL, Xu H, Du JP, Zhang DW, et al. Resting heart rate associates with one-year risk of major adverse cardiovascular events in patients with acute coronary syndrome after percutaneous coronary intervention. Exp Biol Med 2016; 241: 478-84
  8. Palatini P. Heart rate and the cardiometabolic risk. Curr Hypertens Rep 2013; 15: 253-9
  9. Kennedy A, Finlay DD, Guldenring D, Bond R, Moran K, McLaughlin J. The cardiac conduction system: generation and conduction of the cardiac ımpulse. Crit Care Nurs Clin North Am 2016; 28: 269-79
  10. Atterhög JH, Loogna E. P-R interval in relation to heart rate during exercise and the influence of posture and autonomic tone. J Electrocardiol 1977; 10: 331-6
  11. Levine GN, Bates ER, Bittl JA, Brindis RG, Fihn SD, Fleisher LA, et al. 2016 ACC/AHA guideline focused update on duration of dual antiplatelet therapy in patients with coronary artery disease: a report of the American College of Cardiology/American Heart Association Task Force on clinical practice guidelines. J Am Coll Cardiol 2016; 68: 1082-115
  12. Neumann FJ, Sousa-Uva M, Ahlsson A, Alfonso F, Banning AP, Benedetto U, et al. 2018 ESC/EACTS Guidelines on myocardial re